Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl] thieno [3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea

EU orphan designation number: EU/3/12/1001
Active ingredient: 1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl] thieno [3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea
Indication: Treatment of ovarian cancer
Sponsor: AbbVie Ltd
Maidenhead, SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Orphan designation EMA/OD/002/12 (2012)3845 of 06/06/2012
01/02/2013 Transfer of orphan designation EMA/OD/002/12/T/01 (2013)601 of 30/01/2013
22/04/2015 Removal of orphan designation from Community Register